MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmicb.2024.1366744

Медицинская библиотека · Frontiers in microbiology · 2024

From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients.

Huang Furong, Lyu Bo, Xie Fanci, Li Fang, Xing Yufeng, Han Zhiyi, Lai Jianping, Ma Jinmin, Zou Yuanqiang, Zeng Hua, Xu Zhe, Gao Pan, Luo Yonglun, Bolund Lars, Tong Guangdong, Fengping Xu

СтатьяПеревод пока не подготовлен

Аннотация

Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized for its global prevalence and potential progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH). The gut microbiota plays a pivotal role in the pathogenesis of NAFLD, yet the detailed characteristics and ecological alterations of gut microbial communities during the progression from non-alcoholic fatty liver (NAFL) to NASH remain poorly understood.

Methods

In this study, we conducted a comparative analysis of gut microbiota composition in individuals with NAFL and NASH to elucidate differences and characteristics. We utilized 16S rRNA sequencing to compare the intestinal gut microbiota among a healthy control group (65 cases), NAFL group (64 cases), and NASH group (53 cases). Random forest machine learning and database validation methods were employed to analyze the data.

Results

Our findings indicate a significant decrease in the diversity of intestinal flora during the progression of NAFLD (p < 0.05). At the phylum level, high abundances of Bacteroidetes and Fusobacteria were observed in both NAFL and NASH patients, whereas Firmicutes were less abundant. At the genus level, a significant decrease in Prevotella expression was seen in the NAFL group (AUC 0.738), whereas an increase in the combination of Megamonas and Fusobacterium was noted in the NASH group (AUC 0.769). Furthermore, KEGG pathway analysis highlighted significant disturbances in various types of glucose metabolism pathways in the NASH group compared to the NAFL group, as well as notably compromised flavonoid and flavonol biosynthesis functions. The study uncovers distinct microbiota characteristics and microecological changes within the gut during the transition from NAFL to NASH, providing insights that could facilitate the discovery of novel biomarkers and therapeutic targets for NAFLD.

Для цитирования: Huang Furong, Lyu Bo, Xie Fanci, Li Fang, Xing Yufeng, Han Zhiyi, Lai Jianping, Ma Jinmin, Zou Yuanqiang, Zeng Hua, Xu Zhe, Gao Pan, Luo Yonglun, Bolund Lars, Tong Guangdong, Fengping Xu. From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients.. Frontiers in microbiology. 2024. DOI: 10.3389/fmicb.2024.1366744.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.